Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy. / Ryberg, Marianne; Nielsen, Dorte; Osterlind, Kell; Andersen, Per Kragh; Skovsgaard, T.; Dombernowsky, Per.

In: Breast Cancer Research and Treatment, No. 91, 2005, p. 217-225.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ryberg, M, Nielsen, D, Osterlind, K, Andersen, PK, Skovsgaard, T & Dombernowsky, P 2005, 'Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy', Breast Cancer Research and Treatment, no. 91, pp. 217-225.

APA

Ryberg, M., Nielsen, D., Osterlind, K., Andersen, P. K., Skovsgaard, T., & Dombernowsky, P. (2005). Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy. Breast Cancer Research and Treatment, (91), 217-225.

Vancouver

Ryberg M, Nielsen D, Osterlind K, Andersen PK, Skovsgaard T, Dombernowsky P. Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy. Breast Cancer Research and Treatment. 2005;(91):217-225.

Author

Ryberg, Marianne ; Nielsen, Dorte ; Osterlind, Kell ; Andersen, Per Kragh ; Skovsgaard, T. ; Dombernowsky, Per. / Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy. In: Breast Cancer Research and Treatment. 2005 ; No. 91. pp. 217-225.

Bibtex

@article{6d012d4074c311dbbee902004c4f4f50,
title = "Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy",
abstract = "breast cancer; CNS metastases; competing risk analysis; epirubicin; lactate dehydrogenase; predictive factor",
author = "Marianne Ryberg and Dorte Nielsen and Kell Osterlind and Andersen, {Per Kragh} and T. Skovsgaard and Per Dombernowsky",
year = "2005",
language = "English",
pages = "217--225",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer",
number = "91",

}

RIS

TY - JOUR

T1 - Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy

AU - Ryberg, Marianne

AU - Nielsen, Dorte

AU - Osterlind, Kell

AU - Andersen, Per Kragh

AU - Skovsgaard, T.

AU - Dombernowsky, Per

PY - 2005

Y1 - 2005

N2 - breast cancer; CNS metastases; competing risk analysis; epirubicin; lactate dehydrogenase; predictive factor

AB - breast cancer; CNS metastases; competing risk analysis; epirubicin; lactate dehydrogenase; predictive factor

M3 - Journal article

SP - 217

EP - 225

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 91

ER -

ID: 93399